Clinical trial • Phase II • Immunology

Q702 for Chronic graft-versus-host disease

Phase II trial of Q702 for Chronic graft-versus-host disease. 16 participants.

Overview

Trial Therapeutic Area
Immunology
Trial Disease
Chronic graft-versus-host disease
Trial Stage
Phase II

Key dates

Initial CTIS Submission Date
29-07-2025
First CTIS Authorization Date
24-11-2025

Trial design

Phase II trial across 10 sites in Spain.

Target Sample Size
16

Eligibility

Recruits 16 Vulnerable population selected; no details on consent or assent handling provided in the record..

Vulnerable Population
Vulnerable population selected; no details on consent or assent handling provided in the record.

Recruitment

Planned Sample Size
16
Recruitment Window Months
39
Consent Approach
No details on informed consent or assent provided; vulnerable population selected.

Geography

Total Number Of Sites
10
Total Number Of Participants
16

Spain

Earliest CTIS Part Ii Submission Date
07-11-2025
Latest Decision Or Authorization Date
19-01-2026
Processing Time Days
73
Number Of Sites
10
Number Of Participants
16

Sites

Site Name
Hospital Universitario Y Politecnico La Fe
Department Name
Hematology
Contact Person Name
Jaime Sanz Caballer
Contact Person Email
sanz_jai@gva.es
Site Name
Hospital Clinic De Barcelona
Department Name
Hematology
Contact Person Name
Carmen Martinez Munoz
Contact Person Email
CMARTI@clinic.cat
Site Name
University Hospital Virgen Del Rocio S.L.
Department Name
Hematology
Contact Person Name
Jose Antonio Perez Simon
Site Name
Clinica Universidad De Navarra
Department Name
Hematology
Contact Person Name
Sara Villar Fernandez
Contact Person Email
svillar@unav.es
Site Name
Hospital Universitario Puerta De Hierro De Majadahonda
Department Name
Hematology
Contact Person Name
Rafael Francisco Duarte Palomino
Contact Person Email
rafael.duarte@uam.es
Site Name
Hospital Universitario Marques De Valdecilla
Department Name
Hematology
Contact Person Name
Maria Aranzazu Bermudez Rodriguez
Contact Person Email
maria.bermudez@scsalud.es
Site Name
Hospital Clinico Universitario De Valencia
Department Name
Hematology
Contact Person Name
Jose Luis Pinana Sanchez
Contact Person Email
pinana_jos@gva.es
Site Name
Hospital General Universitario Gregorio Maranon
Department Name
Hematology
Contact Person Name
Mi Kwon
Contact Person Email
mi.kwon@salud.madrid.org
Site Name
University Clinical Hospital Virgen De La Arrixaca
Department Name
Hematology
Contact Person Name
Andres Sanchez Salinas
Contact Person Email
andres.sanchez3@carm.es
Site Name
Hospital Universitario Regional De Malaga
Department Name
Hematology
Contact Person Name
Maria Jesus Pascual Cascon

Sponsor

Primary sponsor

Full Name
Qurient Co. Ltd.
Organisation Type
Pharmaceutical company
Country Of Registered Address
Korea, Republic of

Investigational products

Investigational Product Name
Q702

Related trials

Other published trials that may interest you.